Full-Time

Director of Oncology Collaborations

Doc

Posted on 9/9/2024

Natera

Natera

1,001-5,000 employees

Genetic testing and diagnostics solutions provider

Biotechnology
Healthcare

Compensation Overview

$240k - $250kAnnually

+ Restricted-Stock Units

Senior

United States

Territory includes the Central US Region.

Category
Physicians & Surgeons
Medical, Clinical & Veterinary
Required Skills
Sales
Marketing
PowerPoint/Keynote/Slides
Requirements
  • BA in Business, Marketing, or a related field is required; MBA preferred.
  • Background in medical or biological sciences is preferred.
  • Minimum 5 years of experience in strategic Oncology sales to the aforementioned targets across the United States preferred.
  • Market knowledge and experience in Pathology, Oncology & Laboratory sales preferred.
  • Proficient in Microsoft PowerPoint and Excel; Gmail; Salesforce.com.
Responsibilities
  • Become an expert in Natera’s technology and service offerings and represent the company and its business interests at the highest levels with KOL Physicians, Academic/Community Medical Directors, and C-Suite level targets.
  • Develop and execute plans to ensure the rapid distribution of all products.
  • Establish positive working relationships with all key customer segments (internal and external).
  • Educate and recruit Key Opinion Leaders from the Oncology/Hematology medical community.
  • Allocate time as defined with the VP, in the field with ADs, RDs, DMs, DOCCs, and COS to provide direction and feedback to maximize potential collaboration opportunities.
  • Provide direction based on field input, market assessments, and trends to develop an Area which is consistently implementing "Best Practices".
  • Develop business plans based on sales goals, expectations, and available resources, including “Area” strategies and tactics.
  • Attend local, regional, and national trade shows, meetings & trainings.
  • Educate and recruit Strategic Accounts and Lab Partners to offer Natera’s portfolio of tests.
  • Work effectively with Natera's clinical field sales team to help maximize potential business opportunities and partnerships.
  • Perform with a sense of urgency, with a focus on achieving exceptional revenue growth.
  • Play a critical role in the success of the organization.

Natera focuses on genetic testing and diagnostics, providing advanced solutions for cancer patients, transplant patients, and individuals assessing hereditary health risks. Their main technology is cell-free DNA (cfDNA) testing, which analyzes DNA fragments in the blood to detect minimal traces of cancer and assess organ health. Natera differentiates itself by offering specialized tests like the Signatera ctDNA test and Panorama NIPT for prenatal screening, along with genetic counseling services. The company's goal is to enhance patient care through accurate testing and personalized guidance.

Company Stage

IPO

Total Funding

$149.9M

Headquarters

Austin, Texas

Founded

2004

Growth & Insights
Headcount

6 month growth

9%

1 year growth

25%

2 year growth

66%
Simplify Jobs

Simplify's Take

What believers are saying

  • Increased demand for liquid biopsy techniques boosts Natera's cfDNA testing solutions.
  • Telehealth expansion aligns with Natera's remote genetic counseling services.
  • Growing personalized medicine trend enhances relevance of Natera's ctDNA tests.

What critics are saying

  • Hindenburg report alleges deceptive sales practices, risking legal challenges and reputational damage.
  • New Prospera Heart features may face slow adoption by healthcare providers.
  • Fetal RhD NIPT demand may decline post-RhIg shortage, impacting revenue.

What makes Natera unique

  • Natera's Signatera test offers personalized ctDNA analysis for cancer patients.
  • Prospera Heart test uses unique Donor Quantity Score for transplant rejection detection.
  • Fetal RhD NIPT test addresses RhIg shortage, offering early fetal RhD status detection.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Flexible medical plans

Investment options

Time off

Workplace perks

INACTIVE